NCT04227483View on ClinicalTrials.gov

Deflazacort Vs. Prednisolone in Acute-stage ABPA

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 15, 2020

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Allergic Bronchopulmonary Aspergillosis
Interventions
DRUG

Deflazacort

Deflazacort for 4 months

DRUG

Prednisolone

Prednisolone for 4 months

Trial Locations (1)

160012

Chest Clinic, Dept. of Pulmonary Medicine, Chandigarh

All Listed Sponsors
lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER

NCT04227483 - Deflazacort Vs. Prednisolone in Acute-stage ABPA | Biotech Hunter | Biotech Hunter